Healthcare Equipment and Supplies
Company Overview of Affinimark Technologies, Inc.
Affinimark Technologies, Inc. develops diagnostic medical devices to detect the existence of cerebrospinal fluid leaks and for diagnosis of early-stage prostate cancer. Affinimark Technologies, Inc. was incorporated in 2007 and is based in New Haven, Connecticut.
300 George Street
New Haven, CT 06511
Founded in 2007
Key Executives for Affinimark Technologies, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Affinimark Technologies, Inc., please visit www.affinimark.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.